choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Eliquis

Eliquis Newsletter
  • Pfizer taps former Novartis exec to lead cancer drug push 06 Feb 2025 17:06 GMT

    … the years ahead. The pharmaceutical giant said Jeffrey Legos … its COVID-19 vaccine Comirnaty and treatment Paxlovid, as … top-selling drugs, including Xtandi and Eliquis, will lose … developing with biotechnology company Arvinas. One antibody-drug conjugate …

  • Canadian Online Pharmacies – Providing an Alternative to High American Drug Prices 05 Feb 2025 20:24 GMT

    … at least 250 branded medications effective Jan 1, … brand and generic pharmaceutical manufacturers that American … Doctor, family and friend referrals continue to be Planet Drugs … PlanetDrugsDirect.com. Drug GoodRX SingleCare PlanetDrugsDirect.com Eliquis – 2.5mg …

  • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript 05 Feb 2025 13:15 GMT

    … and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings … transformative medicine with over 1 million patients on treatment around … knee replacement study versus Eliquis, so can you talk … for example, they’re vaccinated against the organisms of …

  • Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet 05 Feb 2025 05:16 GMT

    … . Other products such as Eliquis, Nurtec, Vyndaqel and Ibrance … Abrysvo underperformed expectations. RSV vaccine Abrysvo specifically floundered in … upon consultation with a doctor. Outside of the new … footing in the hot antibody-drug conjugate (ADC) market, …

  • Kyleena interactions: Alcohol, medications, and other factors 03 Feb 2025 14:59 GMT

    … check for drug-drug interactions in clinical trials of Kyleena. … as with supplements, foods, vaccines, or even lab tests. … , Eliquis, Xarelto, be sure to tell your doctor before … doctor or another healthcare professional before taking any medication. The drug

  • BMS extends its cost-cutting drive by another $2bn 06 Feb 2025 23:00 GMT

    … top-selling medicines, including cancer immunotherapy Opdivo (nivolumab) and anticoagulant Eliquis (apixaban … due to generic competition for drugs like Revlimid (lenalidomide) and Abraxane … the recent approval by the FDA of its new schizophrenia therapy …

  • Bristol Myers Squibb Expands Cost-Cutting Target to $2 Billion by 2027 06 Feb 2025 16:13 GMT

    … sales of products such as Eliquis and Opdivo3. However, the … patent cliffs for key drugs and the need to invest … #47;www.fiercebiotech.com/biotech/;bristol-myers-cutting-15b … get special offers from American Pharmaceutical Review – all delivered right to …

  • Lower dose of popular blood thinners for VTE may reduce risk for bleeding, hospital visits 06 Feb 2025 15:10 GMT

    … Researchers at Michigan Medicine conducted a registry- … Eliquis; Bristol Myers Squibb, Pfizer) or rivaroxaban (Xarelto, Janssen Pharmaceuticals … with all anticoagulant drugs, including direct oral … important that doctors understand the randomized trials that …

  • Should You Pick PFE Stock At $25? 05 Feb 2025 16:56 GMT

    … its experimental sickle cell disease treatment. If you want upside with … rise for Eliquis. Also, Paxlovid, Pfizer’s Covid-19 antiviral pill, generated … account the changes to the Medicare program, resulting in a hit …

  • Bristol-Myers Squibb Co (BMY) Stock Price Could Reach $66: Morningstar Research 07 Feb 2025 11:52 GMT

    … -oncology (Opdivo) and cardiovascular treatments (Eliquis) ensures sustained pricing power and … to replicate than traditional chemical drugs. This creates an additional … exclusivity for critical drugs like Revlimid, Opdivo, and Eliquis presents significant …

Satisfied with the content?

Continue to create your account.